Does Age Affect the Response to Zinc Therapy for Diarrhoea in Bangladeshi Infants?
AUTOR(ES)
Walker, Christa L. Fischer
FONTE
International Centre for Diarrhoeal Disease Research
RESUMO
The benefit of zinc for the treatment of diarrhoea in a cluster-randomized trial of children, aged 3–59 months, living in rural Bangladesh was previously reported. Here, the benefits of zinc stratified by age—3–5 months, 6–11 months, and 12–59 months—are reported. Although the sample sizes in the stratified groups were too small to detect statistical significance in the 3–5-month and 6–11-month age-groups, the trends suggest that there may be a benefit of zinc for the treatment of diarrhoea on the duration of diarrhoea and on subsequent morbidity and mortality. Additional research is needed to better understand the effect of zinc for the treatment of diarrhoea among infants aged less than six months.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2740681Documentos Relacionados
- Is rice based oral rehydration therapy effective in young infants?
- Effect of zinc supplementation started during diarrhoea on morbidity and mortality in Bangladeshi children: community randomised trial
- Introduction of Routine Zinc Therapy for Children with Diarrhoea: Evaluation of Safety
- Is nitric oxide effective in preterm infants?
- Oral zinc for treating diarrhoea in children
